140 related articles for article (PubMed ID: 16142442)
1. Estrogen metabolizing polymorphisms and breast cancer risk among older white women.
Modugno F; Zmuda JM; Potter D; Cai C; Ziv E; Cummings SR; Stone KL; Morin PA; Greene D; Cauley JA
Breast Cancer Res Treat; 2005 Oct; 93(3):261-70. PubMed ID: 16142442
[TBL] [Abstract][Full Text] [Related]
2. Possible risk modification by polymorphisms of estrogen metabolizing genes in familial breast cancer susceptibility in an Indian population.
Syamala VS; Syamala V; Sheeja VR; Kuttan R; Balakrishnan R; Ankathil R
Cancer Invest; 2010 Mar; 28(3):304-11. PubMed ID: 19863350
[TBL] [Abstract][Full Text] [Related]
3. Impact of CYP1A1 and COMT genotypes on breast cancer risk in Mexican women: a pilot study.
Moreno-Galván M; Herrera-González NE; Robles-Pérez V; Velasco-Rodríguez JC; Tapia-Conyer R; Sarti E
Int J Biol Markers; 2010; 25(3):157-63. PubMed ID: 20878621
[TBL] [Abstract][Full Text] [Related]
4. Soy isoflavones, CYP1A1, CYP1B1, and COMT polymorphisms, and breast cancer: a case-control study in southwestern China.
Wang Q; Li H; Tao P; Wang YP; Yuan P; Yang CX; Li JY; Yang F; Lee H; Huang Y
DNA Cell Biol; 2011 Aug; 30(8):585-95. PubMed ID: 21438753
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.
Huang CS; Chern HD; Chang KJ; Cheng CW; Hsu SM; Shen CY
Cancer Res; 1999 Oct; 59(19):4870-5. PubMed ID: 10519398
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of estrogen synthesizing and metabolizing genes and breast cancer risk in Japanese women.
Miyoshi Y; Noguchi S
Biomed Pharmacother; 2003 Dec; 57(10):471-81. PubMed ID: 14637391
[TBL] [Abstract][Full Text] [Related]
7. Lack of association between catechol-O-methyltransferase Val108/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controls.
Mao C; Wang XW; Qiu LX; Liao RY; Ding H; Chen Q
Breast Cancer Res Treat; 2010 Jun; 121(3):719-25. PubMed ID: 20464630
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival.
Long JR; Cai Q; Shu XO; Cai H; Gao YT; Zheng W
Pharmacogenet Genomics; 2007 May; 17(5):331-8. PubMed ID: 17429315
[TBL] [Abstract][Full Text] [Related]
9. Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women.
Hefler LA; Tempfer CB; Grimm C; Lebrecht A; Ulbrich E; Heinze G; Leodolter S; Schneeberger C; Mueller MW; Muendlein A; Koelbl H
Cancer; 2004 Jul; 101(2):264-9. PubMed ID: 15241822
[TBL] [Abstract][Full Text] [Related]
10. Association of single nucleotide polymorphisms in CYP1B1 and COMT genes with breast cancer susceptibility in Indian women.
Yadav S; Singhal NK; Singh V; Rastogi N; Srivastava PK; Singh MP
Dis Markers; 2009; 27(5):203-10. PubMed ID: 20037207
[TBL] [Abstract][Full Text] [Related]
11. Association of estrogen receptor alpha polymorphisms with breast cancer risk in older Caucasian women.
Modugno F; Zmuda JM; Potter D; Cai C; Ziv E; Cummings SR; Stone KL; Morin PA; Greene D; Cauley JA
Int J Cancer; 2005 Oct; 116(6):984-91. PubMed ID: 15856463
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in genes involved in the estrogen pathway and mammographic density.
Dumas I; Diorio C
BMC Cancer; 2010 Nov; 10():636. PubMed ID: 21092186
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of breast cancer risk in a multigenic model including low penetrance genes involved in xenobiotic and estrogen metabolisms.
Delort L; Satih S; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ
Nutr Cancer; 2010; 62(2):243-51. PubMed ID: 20099199
[TBL] [Abstract][Full Text] [Related]
14. [Relation between single nucleotide polymorphism in estrogen-metabolizing genes COMT, CYP17 and breast cancer risk among Chinese women].
Tan W; Qi J; Xing DY; Miao XP; Pan KF; Zhang L; Lin DX
Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):453-6. PubMed ID: 14575568
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and breast cancer risk in Chinese women: results from the shanghai breast cancer study and a meta-analysis.
Wen W; Cai Q; Shu XO; Cheng JR; Parl F; Pierce L; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):329-35. PubMed ID: 15734954
[TBL] [Abstract][Full Text] [Related]
16. Genetic susceptibility of catechol-O-methyltransferase polymorphism in Japanese patients with breast cancer.
Inoue H; Shibuta K; Matsuyama A; Yoshinaga K; Sadanaga N; Ueo H; Barnard GF; Mori M
Oncol Rep; 2005 Sep; 14(3):707-12. PubMed ID: 16077979
[TBL] [Abstract][Full Text] [Related]
17. CYP17, catechol-o-methyltransferase, and glutathione transferase M1 genetic polymorphisms, lifestyle factors, and breast cancer risk in women on Prince Edward Island.
Cribb AE; Joy Knight M; Guernsey J; Dryer D; Hender K; Shawwa A; Tesch M; Saleh TM
Breast J; 2011; 17(1):24-31. PubMed ID: 21129090
[TBL] [Abstract][Full Text] [Related]
18. Association of COMT haplotypes and breast cancer risk in caucasian women.
Peterson NB; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Huang Y; Chanock SJ; Haines JL; Egan KM
Anticancer Res; 2010 Jan; 30(1):217-20. PubMed ID: 20150638
[TBL] [Abstract][Full Text] [Related]
19. COMT Val158Met polymorphism and breast cancer risk: evidence from 26 case-control studies.
Ding H; Fu Y; Chen W; Wang Z
Breast Cancer Res Treat; 2010 Aug; 123(1):265-70. PubMed ID: 20130981
[TBL] [Abstract][Full Text] [Related]
20. The catechol-O-methyltransferase (COMT) gene polymorphism and prevalence of uterine fibroids.
de Oliveira E; de Aquino Castro R; Gomes MT; da Silva ID; Baracat EC; de Lima GR; Sartori MG; Girão MJ
Maturitas; 2008; 60(3-4):235-8. PubMed ID: 18752908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
